[HTML][HTML] Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases

…, M Ogino, G MacLaren, D Brodie, K Shekar - The Lancet …, 2020 - thelancet.com
WHO interim guidelines recommend offering extracorporeal membrane oxygenation (ECMO)
to eligible patients with acute respiratory distress syndrome (ARDS) related to coronavirus …

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

…, M McMullan, Y Mehta, MT Ogino, ML Paden, K Shekar… - The Lancet, 2020 - thelancet.com
Background Multiple major health organisations recommend the use of extracorporeal
membrane oxygenation (ECMO) support for COVID-19-related acute hypoxaemic respiratory …

Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization

…, AA Rabie, L Salazar, M Schmidt, K Shekar… - Asaio …, 2021 - journals.lww.com
Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization (ELSO)
for the role of extracorporeal membrane oxygenation (ECMO) for patients with severe …

Extracorporeal life support organization coronavirus disease 2019 interim guidelines: a consensus document from an international group of interdisciplinary …

K Shekar, J Badulak, G Peek, U Boeken, HJ Dalton… - Asaio …, 2020 - journals.lww.com
Disclaimer: The Extracorporeal Life Support Organization (ELSO) Coronavirus Disease 2019
(COVID-19) Guidelines have been developed to assist existing extracorporeal membrane …

[HTML][HTML] Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis

K Ramanathan, K Shekar, RR Ling, RP Barbaro… - Critical care, 2021 - Springer
Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients

R Lorusso, K Shekar, G MacLaren, M Schmidt… - Asaio …, 2021 - journals.lww.com
Over the past decade, the use of extracorporeal membrane oxygenation (ECMO) has increased
exponentially, from approximately 30–40 patients per year in the United States 20 years …

Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation

K Shekar, JF Fraser, MT Smith, JA Roberts - Journal of critical care, 2012 - Elsevier
Extracorporeal membrane oxygenation (ECMO) is a form of prolonged cardiopulmonary
bypass used to temporarily sustain cardiac and/or respiratory function in critically ill patients. …

[HTML][HTML] Extracorporeal cardiopulmonary resuscitation in adults: evidence and implications

…, J Bělohlávek, FS Taccone, N Aissaoui, K Shekar… - Intensive Care …, 2022 - Springer
Rates of survival with functional recovery for both in-hospital and out-of-hospital cardiac arrest
are notably low. Extracorporeal cardiopulmonary resuscitation (ECPR) is emerging as a …

Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome

VA Cuddapah, RB Pillai, KV Shekar, JB Lane… - Journal of medical …, 2014 - jmg.bmj.com
Background Rett syndrome (RTT), a neurodevelopmental disorder that primarily affects girls,
is characterised by a period of apparently normal development until 6–18 months of age …

[HTML][HTML] Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation

K Shekar, JA Roberts, CI Mcdonald, S Fisquet… - Critical care, 2012 - Springer
Introduction Extracorporeal membrane oxygenation (ECMO) is a supportive therapy, with its
success dependent on effective drug therapy that reverses the pathology and/or normalizes …